We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DRAXIS and University of Toronto Drop Anipryl Lawsuits

Law360 (November 19, 2003, 12:00 AM EST) -- DRAXIS Health, the University of Toronto and the University's Innovation Foundation have mutually agreed to settle their lawsuits over canine medicine Anipryl, the organizations said in a statement.

They said the settlement involved no payments. The animal health subsidiary of DRAXIS will continue to license the animal health applications of l-deprenyl technologies owned by UTIF.

On July 28, 2000, the University of Toronto announced that negotiations with drug manufacturer Draxis had ended and that it had filed a $100 million lawsuit claiming that Anipryl belongs the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.